# The Human Medicines Regulations 2012, Paragraph 9


Instructions for proper use of the product including in particular—
(a) the dosage;
(b) the method and, if necessary, route of administration;
(c) the frequency of administration (including, if necessary, specifying times at which the product may or must be administered);
(d) the duration of treatment if this is to be limited;
(e) symptoms of an overdose and the action, if any, to be taken in case of an overdose;
(f) what to do if one or more doses have not been taken;
(g) an indication, if necessary, of the risk of withdrawal effects; and
(h) a specific recommendation to consult a doctor or pharmacist, as appropriate, for further explanation of the use of the product.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/27/paragraph/9 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-27/paragraph-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.